Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11039	Companies
241963	Keywords
170394	Articles
130280	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 10/30/2025 at 22:59, 10 months 22 days ago

Biophytis Reports First-Half 2025 Results and Provides Strategic Update
Biophytis reports financial results for the first half of 2025, strategic update, and key achievements in sarcopenia and obesity. Plans for Phase 2 and Phase 3 studies outlined with focus on sustaining growth and value creation

Financial Results Biophytis Sarcopenia Strategic Update Obesity
BRIEF

published on 10/13/2025 at 07:05, 11 months 8 days ago

Biophytis and Asian Investors to Launch Phase 3 Sarcopenia Trial

Biophytis Phase 3 Trial Sarcopenia BIO101 Asian Investors
BRIEF

published on 10/13/2025 at 07:05, 11 months 8 days ago

Biophytis et Partenaires Asiatiques Lancent un Essai Clinique Historique

Biophytis Essai Clinique Sarcopénie BIO101 Coentreprise Hong Kong
REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 11 months 8 days ago

BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
BIOPHYTIS et un consortium d'investisseurs lancent le premier essai clinique de Phase 3 dans la sarcopénie, avec une coentreprise à Hong Kong et un investissement de 20 M$. Opérations cliniques prévues début 2026

Biophytis Investisseurs Essai Clinique Coentreprise Sarcopénie
REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 11 months 8 days ago

BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
BIOPHYTIS and a Consortium of Investors partner to finance and launch Phase 3 Trial in Sarcopenia, creating a joint venture in Hong Kong with US$20 million investment for clinical operations starting early 2026

Biophytis Joint Venture Phase 3 Trial Sarcopenia Consortium Of Investors
PRESS RELEASE

published on 10/13/2025 at 06:59, 11 months 8 days ago

BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
Biophytis et un consortium d'investisseurs, dont Ronghui Renhe Life Technology, s'unissent pour lancer l'essai clinique de Phase 3 en sarcopénie, avec une coentreprise à Hong-Kong

Biophytis Essai Clinique Coentreprise Sarcopénie Consortium D'investisseurs
BRIEF

published on 09/30/2025 at 07:05, 11 months 21 days ago

Biophytis Renforce Sa Présence sur la Scène Internationale au 4ème Trimestre 2025

Biophytis Partenariats Sarcopénie Biotechnologies Événements Internationaux
BRIEF

published on 09/30/2025 at 07:05, 11 months 21 days ago

Biophytis to Engage in Key Events in Q4 2025

Biophytis Partnerships Longevity Sarcopenia Biotechnology Events
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 11 months 21 days ago

Biophytis annonce sa participation à quatre événements clés au cours du 4ème trimestre 2025
Biophytis annonce sa participation à quatre événements clés internationaux au 4ème trimestre 2025 pour présenter ses avancées dans la santé et renforcer ses partenariats

Biophytis Développement Participation Événements Clés 4ème Trimestre 2025
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 11 months 21 days ago

Biophytis to Participate in Four Key Events in Q4 2025
Biophytis to participate in four major international events in Q4 2025, showcasing its progress in transformative therapies impacting longevity and seeking new partnerships

Biophytis Partnerships Longevity International Events Transformative Therapies

Accesswire

Published on 09/22/2026 at 00:00, 50 minutes ago

Alset AI Announces Shares for Debt Transaction
Published on 09/21/2026 at 15:45, 9 hours 5 minutes ago

Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 10 hours 30 minutes ago

Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 10 hours 45 minutes ago

Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 10 hours 50 minutes ago

Dateline Files Motion to Resume Operations at Colosseum

View all ACCESSWIRE

EQS Group

Published on 09/21/2026 at 22:05, 2 hours 45 minutes ago

Abivax Presents Business Updates and First Half 2026 Financial Results
Published on 09/21/2026 at 22:05, 2 hours 45 minutes ago

Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
Published on 09/21/2026 at 20:34, 4 hours 16 minutes ago

BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 19:00, 5 hours 50 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 14 septembre 2026 au 18 septembre 2026
Published on 09/21/2026 at 18:00, 6 hours 50 minutes ago

Cham Swiss Properties places bond of CHF 100 million

Les Echos

Published on 09/21/2026 at 18:19, 6 hours 31 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 6 hours 31 minutes ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 6 hours 49 minutes ago

Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 7 hours 4 minutes ago

WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 7 hours 4 minutes ago

WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026

View all LES ECHOS COMFI WIRE